UBS has issued a research report downgrading Hang Lung PPT (00101) from "Buy" to "Neutral." The downgrade follows the stock reaching the bank's target price, with expectations that catalysts for a revaluation are unlikely in the short term. The target price has been maintained at HK$9.6. UBS believes there is limited room for the company to increase dividend payouts in the near future, as its operating cash flow is only just sufficient to cover annual dividends. Additionally, the full operational launch of Westlake 66 in Hangzhou will take time, with several top luxury brands yet to formally open stores. The company's asset monetization process remains slow, with limited transactions at its luxury residential project "The Peak" in Mid-Levels East and no clear timeline for a C-REIT listing. The current stock price implies a projected dividend yield of approximately 5.6% for fiscal year 2026, which is broadly in line with historical averages. UBS believes the market has already largely priced in the company's ability to maintain future dividend per share, which should provide some downside support for the stock price.